A quiet revolution is unfolding in cancer research laboratories—and it has nothing to do with blockbuster drugs or billion-dollar acquisitions. Instead, it centers on a deceptively simple idea: what if cancer cells could be engineered to destroy themselves on command?   In liver cancer research, this concept of "self-destruction" is rapidly gaining traction. As hepatocellular...